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Abstract 1 
Background and aim: The main challenge of assessing diastolic function is the balance between clinical 2 
utility, in the sense of usability and time-efficiency, and overall applicability, in the sense of precision for 3 
the patient under investigation. In this review, we aim to explore the challenges of integrating data in the 4 
assessment of diastolic function and discuss the perspectives of a more comprehensive data integration 5 
approach. 6 
Methods: Review of traditional and novel approaches regarding data integration in the assessment of 7 
diastolic function. 8 
Results: Comprehensive data integration can lead to improved understanding of disease phenotypes and 9 
better relation of these phenotypes to underlying pathophysiological processes - which may help affirm 10 
diagnostic reasoning, guide treatment options, and reduce limitations related to previously unaddressed 11 
confounders. The optimal assessment of diastolic function should ideally integrate all relevant clinical 12 
information with all available structural and functional whole cardiac cycle echocardiographic data – 13 
envisioning a personalized approach to patient care, a high-reaching future goal in medicine. 14 
Conclusion: Complete data integration seems to be a long-lasting goal, the way forward in diastology, 15 
and machine learning seems to be one of the tools suited for the challenge. With perpetual evidence that 16 
traditional approaches to complex problems may not the optimal solution, there is room for a steady and 17 
cautious, and inherently very exciting paradigm shift towards novel diagnostic tools and workflows to 18 
reach a more personalized, comprehensive and integrated assessment of cardiac function. 19 
 20 
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Introduction 1 
The task to non-invasively assess left ventricular (LV) diastolic function and filling pressures 2 
has been an ongoing challenge since the emergence of cardiac ultrasound imaging. The tension lies in the 3 
complexity of diastolic dysfunction as a pathology opposed to a very real-life clinical need to assess it in 4 
a fast and simple workflow. Besides the difficult task of balancing specificity and sensitivity in the 5 
assessment, various proposed guidelines and algorithms also face the challenge of linking arbitrarily 6 
separated grades of dysfunction with clinical outcomes and treatment indications. Oversimplification of 7 
such algorithms has resulted in misclassifications of a large proportion of patients, whereas more complex 8 
algorithms, incorporating increased decision points and parameters, have proved to have low clinical 9 
utility in the real-world practical setting. Achieving a universal approach to the assessment of diastolic 10 
function therefore seems to be an intricate task that can hardly be approached with traditional algorithms, 11 
either simplified or complex. The optimal assessment of diastolic function and filling pressures should 12 
ideally integrate all relevant clinical information with all available structural and functional 13 
echocardiographic data, not a pre-selected set of parameters. The described assessment envisions a 14 
personalized approach to patient care, a high-reaching future goal in medicine.  15 
In this review, we aim to explore the challenges of integrating data in the assessment of diastolic 16 
function and discuss the perspectives of a more comprehensive data integration approach. 17 
 18 
Assessing diastolic function – the quest for a universal approach 19 
 The majority of current ideas and pitfalls surrounding non-invasive assessment of diastolic 20 
function were recognized and defined in the seminal work from Appleton, Hatle and Popp [1], relating 21 
distinct transmitral flow velocity patterns to LV diastolic function. The observed flow patterns were more 22 
related to myocardial dysfunction and hemodynamic status than the type of underlying disease, setting 23 
ground for future classification of diastolic dysfunction into grades (Figure 1). Although these grades are 24 
pathophysiologically interpretable, the patterns of mitral inflow represent a dynamic continuum, changing 25 
with regard to disease progression, medical therapy or alterations in hemodynamic status. Ongoing 26 
research showed that the correlation of mitral inflow parameters and pressure measurements is influenced 27 
by overall cardiac function, resulting in the fact that transmitral flow parameters do not correlate with LV 28 
filling pressures in patients with preserved ejection fraction, whereas they do in reduced LV function [2]. 29 
Interpreting any surrogate diastolic parameter is inherently complex, as most Doppler patterns 30 
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demonstrate varying dependency on the inotropic state, volume loading, ventricular relaxation, chamber 1 
compliance and left atrial pressure, as well as on additional factors such as age, heart rate, blood pressure, 2 
mitral valve pathology, amongst others [3–6]. Therefore, to correctly interpret findings and assess 3 
function, it is crucial to recognize a wider pattern including clinical history, diagnostic data, 4 
echocardiographic patterns and their dynamic changes.  5 
To address these challenges and resolve the ambiguity of the pseudonormalisation pattern, 6 
various additional tests and parameters were suggested over time – the alteration of loading conditions 7 
with a Valsalva test [7], the addition of pulmonary venous velocity curves [8–10] or tissue Doppler 8 
imaging (TDI) [2,11,12] – ultimately resulting in more complex algorithms. As an example, with the 9 
addition of the ratio between early diastolic transmitral flow and TDI velocities of the mitral ring (i.e. 10 
E/e’) the assessment of diastolic function in patients with preserved EF was somewhat simplified. 11 
However, this addition ultimately created a new grayzone in the intermediate range of the ratio, where 12 
further assessment and parameters were mandatory to assess underlying diastolic function (e.g. 13 
pulmonary flow velocities or the Valsalva manoeuvre). [2] This need for a wide combination of 14 
parameters in non-invasive diastolic function assessment, together with alterations of algorithms in 15 
specific patient populations, was thus emphasised in the ASE/EACVI 2009 guidelines for diastolic 16 
assessment [13]. Besides parameters of diastolic function and associated measurements (i.e. mitral inflow 17 
velocities, Valsalva manoeuvre, pulmonary venous flow, TDI velocities etc.), morphologic and functional 18 
correlates of diastolic dysfunction (i.e. LV hypertrophy, left atrial (LA) volume, LA function and 19 
pulmonary artery systolic and diastolic pressures) were also considered. However, the incorporation of 20 
complexity backfired, resulting in a burdensome, sophisticated and multipart algorithm reflective of the 21 
complex underlying pathology, but nevertheless with limited applicability in the clinical setting. The 22 
revised 2016 guidelines [14] hence aimed to reduce and simplify the required measurements for diastolic 23 
dysfunction assessment, selecting only four diastolic function and diastolic function-influenced 24 
parameters for the task (i.e. E/A, E/e’, tricuspid regurgitation velocity and LA indexed volume). The 25 
algorithm flow was modified offering a two-step decision tree now classifying a new subset of patients 26 
with indeterminate function, thus increasing specificity and reducing the diagnosis of first grade 27 
dysfunction [15]. A major limitation of the guidelines was still the lack of consideration of age – where 28 
age influences the findings of diastolic parameters. [16] Recent efforts have been made in addressing the 29 
challenges of age-appropriate interpretation of diastolic patterns by applying age-specific multivariate 30 
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reference regions for echocardiographic parameters commonly used in the evaluation of LV diastolic 1 
function [17], or general population age-based normative values [18], demonstrating  age-specific ranges 2 
to be prognostically relevant and suggesting that such approaches in the classification of LV filling 3 
patterns could lead to more consistent diagnostic algorithms. A further challenge can be found in 4 
assessing diastolic function in atrial fibrillation, where the insights gained from the LA, normally used to 5 
infer diastolic function, are of limited application. Doppler assessment of the LV is limited by the 6 
variability in cycle length and the LA enlargement may be present regardless of filling pressures. Current 7 
guidelines thus recommend measurements should be obtained from averaging at least three cardiac 8 
cycles.  9 
Several studies [19,20] demonstrated that the 2016 guidelines proved to have higher sensitivity 10 
in estimating the filling pressures in patients with reduced EF as compared to the 2009 guidelines, while 11 
the low sensitivity was still present in patients with normal EF and normal filling pressures. However, 12 
more data integration - combining demographic and clinical variables with non-invasive 13 
echocardiographic parameters - showed an incremental value when diagnosing elevated filling pressures. 14 
[21] On the other hand, stratification into diastolic grades has been strained by the lack of relationship to 15 
cardiovascular outcomes, complicating the clinical utility of undergoing complex algorithms to identify a 16 
diastolic class. While various diastolic parameters proved predictive of clinical outcomes in studies [22–17 
26], combining parameters in classifications to define grades showed no consistent relation to outcomes 18 
[27,28] – showing  worse outcomes in moderate/severe compared to mild diastolic dysfunction [29], or 19 
only in severe dysfunction [30]. A universal diastolic grading approach therefore evidently lacked clear 20 
clinical value.   21 
Novel imaging techniques like speckle tracking echocardiography (STE) are also increasingly in 22 
focus, as they can offer a wealth of embedded information on the systolic and diastolic function, and 23 
provide insight into patterns of myocardial mechanics that correlate with diastolic parameters and 24 
cardiovascular outcomes. [14,31] The wealth of data that can be obtained using these techniques is still 25 
under research and therefore clinically underused [32]. Analysis of single-beat STE based LV and LA 26 
volume and strain peak velocity and timing measurements resulted in patient groups with increasing 27 
severity of diastolic dysfunction and LV filling pressures (validated by invasive measurements), proving 28 
that information derived from STE variables can indeed be useful for assessment of diastolic dysfunction. 29 
[38]. Moreover, STE indices of diastolic function showed to be an important discriminator between heart 30 
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failure phenogroups [34]. Deformation data also carries immense information in exercise testing, 1 
especially in the subset of patients with diastolic dysfunction that may have normal hemodynamic profile 2 
at rest but symptoms of heart failure or dyspnoea in effort. Typically, the data from these exercise tests is 3 
complex to integrate and therefore conclusions are reduced to the comparison of only selected 4 
measurements at rest and exercise. 5 
 6 
Assessing function in challenging patients - the limitations of a universal approach 7 
The described overview of non-invasive diastolic function assessment shows, consistently and 8 
somewhat paradoxically, that a universal approach is feasible only by sacrificing precise assessment in 9 
special patient populations where non-invasive parameters and the corresponding patterns are influenced 10 
by related comorbidities. For example, mitral valve disease or regional deformation impairment due to 11 
ischemic disease or genetic-sarcomere mutations can alter the mitral inflow pattern, TDI velocity profile 12 
and the related ratios, resulting in diastolic patterns not reflective of the level of diastolic dysfunction. 13 
These pitfalls can be demonstrated through the comparison of the patients presented in Figures 1-3.  14 
Patterns related to increasing grades of diastolic dysfunction are clearly defined using the guideline-15 
recommended echocardiographic measurements in four hypertensive patients shown in Figure 1. The 16 
patient histories, signs and symptoms are supplemental, describing increased comorbidities, worse 17 
symptoms and a need for more medical therapy in higher grade dysfunction. The STE LV and LA strain 18 
parameters concur, showing overall decreased LV global longitudinal strain in grade I and II, and a more 19 
heterogenic regional LV deformation with basal impairment in grade III. LA strain adds incremental 20 
value to the finding of LA enlargement, reflecting underlying atrial functional dynamics [33]. The three 21 
phases of the atrial cycle - reservoir, conduit and pump function - are reflected in corresponding LA strain 22 
measures – reservoir, conduit and contractile strain. Atrial contraction was used as a zero-reference point 23 
for the deformation assessment, as this analysis results in a more physiological, and easier to visually 24 
assess strain curve, with negative values during LA contraction. Impaired LV relaxation in grade I 25 
dysfunction results in a reduction of LA conduit strain, while the contractile function is augmented to 26 
maintain to LV stroke volume. In more advanced diastolic dysfunction, we can observe a steady 27 
reduction in all components of LA strain. The cases are more challenging in Figure 2.  Patients present 28 
with relatively similar guideline-defined patterns – E/A < 0.8 in the first two patients, similar septal e’ 29 
velocities and E/e’, lack of quantifiable tricuspid regurgitation and an enlarged LA. However, in these 30 
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individuals the clinical and STE data provide a crucial framework for interpreting underlying patient 1 
phenotypes. The first case is a patient presenting with elevated blood pressure at examination, which can 2 
influence the relaxation of the LV. This can be objectively quantified with the LV deformation curves, 3 
showing a post-systolic motion in the basal septum (i.e. a pattern associated with elevated blood pressure 4 
and reflecting delayed LV relaxation [33,34]); whereas the LA strain reflects a relatively preserved atrial 5 
function. Integration of clinical and echo data in the second case reveals long-standing moderate primary 6 
mitral regurgitation-related LV hypertrophy and preserved EF. Due to these confounders, the utility of the 7 
E/A, E/E’, and LA enlargement for diastolic assessment has to be taken with caution. STE imaging gives 8 
some insight, showing a shift in atrial dynamics, with augmented contractile strain and decreased conduit 9 
strain. Additional parameters are needed to assess cardiac function (e.g. IVRT and difference in 10 
pulmonary and mitral A wave duration). Finally, in the last case, the clinical history and STE data provide 11 
important insight – showing severe hypertrophy and severe regional deformation impairment of the 12 
anterolateral wall related to the diagnosis of hypertrophic cardiomyopathy, which is paired with systolic 13 
anterior motion and mild mitral regurgitation. In hypertrophic cardiomyopathy individual variables have 14 
moderate correlation with LV filling pressures, and regional abnormalities in deformation can influence 15 
mitral annulus motion [14]. LA strain again shows a signal of LV relaxation impairment, however 16 
additional parameters are needed to assess the diastolic function.  17 
The described clinical cases outline the challenges of a universal, algorithmic assessment of 18 
diastolic dysfunction. These challenges can be approached either with numerous alterations to a general 19 
algorithm in specific diseases, as suggested in the 2009 and 2016 guidelines, or with comprehensive data 20 
integration that can incorporate and weigh all information relevant to the positioning of patients in the 21 
spectrum of cardiac function abnormalities. The latter seems more attractive and intuitive, and is indeed, 22 
as shown above, applied in everyday workflows using clinical reasoning and experience. Due to complex 23 
relations of diastolic parameters, confidence in assessment of specific patients can only be achieved 24 
through the integration of the complete clinical assessment and complete available data – from clinical to 25 
echocardiographic (Figure 3). 26 
 27 
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Moving towards more comprehensive data integration of the whole cardiac cycle in the assessment 1 
of diastolic function  2 
The addition of whole cardiac cycle data extracted from echocardiographic images (e.g. volume, 3 
blood-pool and myocardial velocity, strain or strain-rate curves) to the assessment of diastolic function 4 
serves as a step towards a more sophisticated data integration strategy. Heterogeneity of diastolic 5 
dysfunction is an appropriate challenge for machine learning (ML), especially unsupervised approaches 6 
[31], which aim to extract hidden patterns in available data and naturally cluster patients regardless of a 7 
priori knowledge or pre-defined clinical labels. Such algorithms have recently been used to approach 8 
diastolic dysfunction classification. Using recommended parameters for diastolic assessment, an 9 
unsupervised clustering approach identified unique patterns of diastolic dysfunction that showed a 10 
relationship to clinical outcomes, as opposed to current grading schemes. [32] Importantly, patients 11 
classified as indeterminate by guidelines were reclassified into an appropriate risk group. In other studies, 12 
a combination of variables (i.e. demographic, clinical, laboratory, ECG and echo) have been used to 13 
explore heart failure phenotypes that differ in outcomes and therapy response [35,36]; and also, to 14 
investigate HF phenogroups with data on invasive hemodynamics, altogether showing that the severity of 15 
diastolic dysfunction seems to be one of the main separating factors between these phenogroups [36,37]. 16 
Precise phenotyping of diastolic function inevitably influences patient care, for example, optimal patient 17 
management requires differentiation between abnormal relaxation, when heart rate reduction is beneficial, 18 
and decreased compliance, when the latter is not the case. [38] The distinction can be found through 19 
comprehensive data assessment incorporating a wide set of parameters, stepping out of the scope of 20 
simplified algorithms of classification. ML approaches can aid in standardizing echocardiographic 21 
evaluation using unlabelled variables without a priori algorithms, isolating prognostic phenotypes not 22 
visualized by guideline algorithms. 23 
In disease exploration, both the traditional consensus-based and the described ML approaches 24 
are constrained to a limited number of key disease markers and clinical variables, such as selected peak 25 
value or timing measurements. These might not capture the full complexity, and subtle changes of the 26 
underlying diseases. Specifically, spatiotemporal patterns of myocardial velocity curves, defined by peak 27 
and timing values throughout the whole cardiac cycle, are reflective of regional and global dysfunction in 28 
systole and diastole [39], and reveal intricate changes in myocardial mechanics in specific cardiac 29 
pathologies [40]. Similarly to when a clinician integrates these data based on previous experience and 30 
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knowledge, novel machine learning techniques offer the possibility to incorporate information embedded 1 
in the velocity data of the whole cardiac cycle, with the aim to extract the maximum amount of 2 
information reflective of cardiac function and disease from cardiac images. This approach could also be 3 
used to analyze the complex changes occurring between rest and exercise echocardiography. Moreover, 4 
as atrial fibrillation still serves as an exclusion criterion in many ML algorithms looking at cardiac echo 5 
measurements [41,42], a whole-cardiac cycle data approach incorporating multiple consecutive beats 6 
could present a potential way forward in addressing this challenge [43]. Moreover, pathology related 7 
information is contained not only in the amplitude and profile of a velocity curve, but likewise in the 8 
timings and durations of different cardiac phases (e.g. isovolumic contraction or early diastole) [44]. 9 
Temporal differences, due to inter-patient variability in heart rate or intra-patient variability between rest 10 
and exercise, result in a challenging interpretation of the relationship between cardiac phases (e.g. when 11 
assessing a shift in the onset of systole/diastole due to dysfunction, see Figure 4).  Since the timings of 12 
cardiac phases can easily be defined with echocardiographic (valve flows) and ECG (onset of atrial 13 
contraction) data, time alignment of echo data is feasible as part of the ML approach [39,43–45]. Velocity 14 
data can be time aligned to a common temporal reference within a patient cohort and quantitatively 15 
compared between patients. Data on the corrected differences in timings can be preserved, and used as an 16 
additional parameter in later analysis.  17 
An important matter to assess is if the theoretical advantage of whole-cardiac cycle data 18 
integration adds any real advantages in disease exploration. To address this question, a ML approach 19 
integrating spatiotemporal information from rest and exercise echocardiographic data (including velocity, 20 
strain and strain rate curves, respectably) was used to create spatiotemporal-rest-exercise representations 21 
of the LV function. [39] This comprehensive whole cardiac cycle data proved more successful than 22 
traditional measurements (e.g. peak amplitudes of systolic and early diastolic velocities, selected peaks 23 
and timings of strain and strain rate measurements, or echocardiographic variables such as LV end-24 
diastolic volumes and LA indexed size) in identifying HFpEF, objectively showing that indeed, 25 
traditional measurements do not exploit all available diagnostic data and represent just a single value 26 
from the information-filled cardiac cycle. Time-alignment also proved useful here and in other studies 27 
[39], improving the characterization of a HFpEF population, showing that the largest variability of 28 
cardiac data is found within the diastolic cardiac phase, especially during exercise.  29 
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A further illustration of the utility of the integration of whole cardiac cycle data, such as TDI 1 
based velocity traces, lies in the valuable possibility of ML to provide patient membership probabilities, 2 
in favour of categorical clinical diagnoses, to diseased (i.e. HF) or healthy groups. For example, 3 
hypertensive and breathless patients have been categorized belonging to a transition zone of the HFpEF 4 
spectrum, thus demonstrating possible culprits of clinical diagnostic algorithms, as well as the spectrum 5 
of the heterogeneous HFpEF syndrome. [43] As part of this process, a pathophysiological interpretation 6 
of TDI patterns related to distinct  patient groups was possible, showing the ability of ML methods to 7 
distinguish alterations in diastolic function in the diseased patient groups – more fusion of early and late 8 
diastolic curves during exercise with similar heart rates, delayed early diastolic lengthening reflective of 9 
relaxation/compliance abnormalities or early vs. late diastolic filling patterns, and increased variability in 10 
the onset of atrial contraction and a failure of peak a’ wave increase during exercise, suggestive of 11 
increased filling pressure. Multi-feature analysis of rest and exercise data, as well as of regional data 12 
opposed to only global, resulted in a better disease assessment than analysing the data independently.[42] 13 
Unsupervised ML has also been used to combine whole-cycle data, specifically LV strain and volume 14 
curves, extracted from standard acquisition protocols, with relevant heterogeneous clinical variables, such 15 
as demographic, ECG and laboratory data, to form a meaningful representation of cardiac function in 16 
each patient, relating it to therapy response[45]. These methods facilitate the fusion of heterogeneous 17 
data, weighing the contribution of each input to the final result, allowing extraction of interpretable 18 
physiological patterns from patient data without the influence of potentially incorrect clinical diagnostic 19 
labels of borderline patients. [44] Indeed, the most controversial, and also the most interesting 20 
contribution of such sophisticated spatiotemporal analysis, might be the way borderline patients are 21 
classified, which may not concur with traditional diagnostic labels, potentially reflecting suboptimal 22 
capability of diagnostic guidelines. [39,43,45] 23 
 24 
Challenges ahead 25 
Besides the time limitations and knowledge requirements, there are other relevant and inherent 26 
challenges when integrating complex data in everyday clinical assessment – selection bias of patients in 27 
analysis, missing data, embedded noise in imaging data, validation of used algorithms and 28 
reproducibility, to name a few. The results of most studies mentioned above are confined to single-center 29 
cohorts or cohorts from selected, well-defined populations [36,43,45]. One of the strongholds of ML 30 
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methods lies in the possibility to incorporate prospective patient data or in testing/validating the 1 
algorithms on different datasets [17,46].  Missing patient data, a relevant problem in clinical practice and 2 
research, has been previously addressed with the exclusion of patients with incomplete data [35,47], 3 
which can heavily bias the conclusions of the analysis. Novel approaches have used data imputation 4 
methods to resolve missing clinical parameters[36,45] or velocity curves [39], potentially increasing the 5 
utility of complex data integration in a real-life setting. As in any deductive process, the quality of 6 
conclusions depends on quality of used information. Complex approaches using imaging data are highly 7 
dependent on image quality and reproducibility of measurements. Strain and strain-rate curves are 8 
burdened with embedded noise. Here novel approaches can be used as noise filtering techniques [48] – 9 
where the most important dimensions/ principal components of data variability capture the major 10 
clinically interpretable patterns, whereas, less relevant ones capture the noise. In the future, data 11 
extraction (e.g.  deformation analysis on available echo images) as well as data preparation (e.g. time 12 
alignment), needed for more complete analysis, could be automated [49,50], thus enabling standardization 13 
through increased reproducibility. Finally, all novel algorithms are in need of being subjected to stringent 14 
validation before incorporation into the clinical environment. A scheme showing the advantages and 15 




The balance between clinical utility, in the sense of usability and time-efficiency, and overall 20 
applicability, in the sense of precision for the patient under investigation, represents the main challenge in 21 
the assessment of diastolic (dys)function. The high-reaching aim of personalized medicine that could 22 
resolve these tensions may be feasible through a more comprehensive integration of all relevant data – 23 
from clinical to whole-cycle echocardiographic data. Complete data integration seems to be a long-lasting 24 
goal, the way forward in diastology, and machine learning seems to be one of the tools suited for the 25 
challenge. Each successful integration of heterogeneous data to patient assessment offers incremental 26 
value to the goal of better understanding complex topics such as diastolic dysfunction or HFpEF. With 27 
more comprehensive approaches we can see improved shaping of disease phenotypes and better relation 28 
of these phenotypes to underlying pathophysiological processes - which may help affirm diagnostic 29 
reasoning, guide treatment options, and reduce limitations related to previously unaddressed confounders. 30 
The aim has slowly shifted from strict categorical classifications of disease/health towards the exploration 31 
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of disease as a continuous spectrum, ranging from health to dysfunction, with the novel goal being 1 
personalized positioning of patients into a certain part of this spectrum. Finally, the main clinical value 2 
can be harvested from relating newfound distinct phenotypes to long-term patient trajectories, a goal 3 
consistently highlighted in contemporary publications. With perpetual proof that traditional approaches to 4 
complex problems are not the optimal solution, there is room for a steady and cautious, and inherently 5 
very exciting paradigm shift towards novel diagnostic tools and workflows to reach a more personalized, 6 
comprehensive and integrated assessment of cardiac function.  7 
 8 
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Figure descriptions 1 
Figure 1 Diastolic assessment using the 2016 guidelines 2 
(Rows) Four hypertensive patients with varying degrees of diastolic dysfunction. (Columns from left to 3 
right) The patient history, signs and symptoms, recommended echocardiographic parameters, and 4 
diastolic grades assessed using the 2016 guidelines [14]. Diastolic dysfunction can be assessed in a 5 
straightforward way using the four echocardiographic parameters proposed by the guidelines. The grade 6 
of dysfunction concurs with the associated clinical picture. NT-proBNP levels were normal in the first 7 
two patients (<14.34 pg/ml), and slightly elevated in the third and fourth (303 and 731 pg/ml, 8 
respectively).  9 
(BMI – body mass index, EF - ejection fraction, DM – diabetes mellitus, ARB - Angiotensin II receptor 10 
blocker, ACEi - Angiotensin-converting-enzyme inhibitors, FA- atrial fibrillation, PW TDI – pulsed wave 11 
tissue Doppler imaging, LAVI – left atrial volume indexed to body surface area, LV GLS – left ventricular 12 
global longitudinal strain, STE – speckle-tracking echocardiography) 13 
 14 
Figure 2 Challenges of diastolic assessment using the 2016 guidelines 15 
(Rows) Three patients with various pathologies: arterial hypertension, moderate mitral insufficiency and 16 
hypertrophic cardiomyopathy. Patient history lays out the framework for interpreting related 17 
echocardiographic findings. Important echo findings are marked in yellow and red. Further discussion can 18 
be found in the text.  19 
(abbreviations same as in Figure 1, CPAP – continuous positive airway pressure, MR – mitral 20 
regurgitation, SAM – systolic anterior motion of the anterior leaflet, PSS – post-systolic shortening) 21 
 22 
Figure 3 An example of data integration in the assessments of a complex patient 23 
A female with long-standing arterial hypertension and clinically diagnosed obstructive hypertrophic 24 
cardiomyopathy. The posterior part of the mitral annulus is calcified, moderate mitral regurgitation is 25 
present, and the basal septum is hypertrophied, measuring 17 mm. All of the latter influence traditional 26 
interpretation of diastolic parameters. Additional investigation is needed. The patient had elevated blood 27 
pressure at assessment, which can influence findings. The obstruction is highest in the midventricular 28 
region, with the gradient reaching 51 mmHg during the Valsalva manoeuvre. During Valsalva, the 29 
inversal of the pseudo-normal mitral inflow can be noted. The E/E’ ratio indicates elevated filling 30 
Bijnens 19 
pressure, supported by the difference in the timings of the pulmonary vein and mitral inflow A wave 1 
duration, LA is enlargement and tricuspid regurgitation velocity.  2 
(abbreviations same as in Figure 1, COPD – chronic obstructive pulmonary disease) 3 
 4 
Figure 4 A scheme showing the utility of temporally aligning velocity traces 5 
(A) Temporal non-correspondence of the velocity traces can be due to inter-subject differences in heart 6 
rate and in the timing of cardiac phases. (B) Temporal alignment can be used to express velocity traces 7 
within a common temporal reference. (C) Temporally aligned velocity traces can be directly compared 8 
between patients enabling the assessment of the onset and duration of cardiac phases. A later onset of 9 
systolic LV ejection, and a prolonged LV ejection and isovolumic relaxation time can be seen in the 10 
patient on the right. This concurs with the delayed and reduced peak aortic velocity and the fusions of the 11 
early and late diastolic filling.  12 
 13 
 Figure 5 An overview of data a more comprehensive approach to data integration 14 
A scheme showing the advantages and challenges of a more comprehensive data integration. 15 
 16 
